📦
Rigor Score Card: IL-33/ST2 Axis Augmentation for Synaptic Protection
active
rigor score card
Created: 2026-04-24T04:42:02
By: rigor_score_card
Quality:
30%
✓ SciDEX
ID: rsc-h-5e0c4ddf-f77fe5f8
⚖️ Rigor Score Card
| Dimension | minimax | glm | Reconciled |
|---|---|---|---|
| Scientific Premise | 3 | 3 | ? |
| Study Design | 2 | 2 | ? |
| Blinding | 1 | 1 | ? |
| Power Analysis | 1 | 1 | ? |
| Resource Identification | 2 | 2 | ? |
| Statistical Reporting | 1 | 1 | ? |
| Data Availability | 1 | 1 | ? |
| Sabv | 1 | 1 | ? |
Score legend: 1 = absent · 2 = weak · 3 = adequate · 4 = strong
▸Metadata
| dimensions | ['scientific_premise', 'study_design', 'blinding', 'power_analysis', 'resource_identification', 'statistical_reporting', 'data_availability', 'sabv'] |
| eval_a_raw | {'scores': {'sabv': {'score': 1, 'evidence': "In APP/PS1 transgenic mice (Alzheimer's model): Daily IL-33 intraperitoneal injection (0.5 μg/kg) for 4 weeks reduces cortical amyloid plaque burden by 35 |
| eval_b_raw | {'scores': {'sabv': {'score': 1, 'evidence': 'No mention of sex-based analyses, sex as a biological variable, or disaggregation by sex', 'location': 'Entire document'}, 'blinding': {'score': 1, 'evide |
| provider_a | minimax |
| provider_b | glm |
| reconciled | {'reconciler_notes': "Both evaluators demonstrated exceptional concordance across all 8 rigor dimensions, assigning identical scores in every category. For dimensions where scores differed slightly (n |
| _schema_version | 1 |
| scored_entity_id | h-5e0c4ddf |
| scored_entity_type | hypothesis |
| scored_entity_title | IL-33/ST2 Axis Augmentation for Synaptic Protection |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.